Appropriate Use of GLP-1 Agonists
Date: 09/13/24
GLP-1 agonists have become part of the standard of care in the treatment of Type II Diabetes according to the American Diabetes Association (ADA) guidelines. We would like to make you aware of the coverage and clinical considerations.
Click here to view the full release (PDF).